PDE6G Antibodies

Santa Cruz Biotechnology provides a broad selection of PDE6G monoclonal antibodies for investigating phosphodiesterase 6 gamma (PDE6G) in various biological processes. PDE6G monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PDE6G is a critical component of the phototransduction pathway in retinal photoreceptor cells, where it plays a vital role in the conversion of light signals into electrical signals. Phosphodiesterase 6 gamma (PDE6G) is essential for normal vision, and mutations can lead to various retinal diseases. Research focused on PDE6G has revealed its significance in maintaining healthy visual function and identifying potential therapeutic targets. Scientists studying vision-related disorders rely on highly specific molecular tools to advance their understanding of retinal biology. Advanced research techniques help illuminate the molecular mechanisms underlying PDE6G function in both normal and pathological conditions. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to make meaningful contributions to vision science and therapeutic development.